Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Lung Neoplasms: HELP
David Planchard
Based on 80 articles published since 2009
(Why 80 articles?)
||||
Expertise Level
The expertise of David Planchard ranks in the
  • Top 0.034%
  • ... of 226,284 published authors worldwide on Lung Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 80 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Planchard, D   ·   Planchard, David
Work Locations
Details
Most likely:    Institut Gustave Roussy      
2018
  • a Medical Oncology Department , Gustave Roussy , Villejuif , France. · b Early Drug Development Department , Gustave Roussy , Villejuif , France. · Pubmed 30457891
  • a Medical Oncology Department , Gustave Roussy , Villejuif , France. · Pubmed 29958099
  • Medical Oncology Unit, University Hospital of Parma, Parma, Italy. · Pathology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy. · Medical Illustrator, Riccione, Italy. · INSERM, U981, Gustave Roussy Cancer Campus, Villejuif, France. · Medical Oncology Unit, University Hospital of Parma, Parma, Italy. Electronic address: · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 29729495
  • Division of Medical Oncology, "S.G. Moscati" Hospital, Avellino, Italy. Electronic address: · Department of Thoracic Oncology, The Netherlands Cancer Institute, The Academic Medical Center, Amsterdam, The Netherlands. · Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille, France. · Department of Medical Oncology, Second University of Naples, Naples, Italy. · Department of Oncology, Istituto Scientifico Romagnolo per lo studio e la Ricerca dei tumori, IRCCS, Meldola, Italy. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI. · Department of Thoracic/Head and Neck Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX. · Hospital Universitario 12 de Octubre, CNIO, Universidad Complutense, Madrid, Spain. · Department of Cancer Medicine Thoracic Unit, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Cancer Research Centre Léon Bérard and Claude Bernard University, Lyon, France. · Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indiana University, Indianapolis, IN. · Division of Medical Oncology, "S.G. Moscati" Hospital, Avellino, Italy. · Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy. · Pubmed 29396237
  • Medical Oncology Department, Gustave Roussy, Villejuif, France. · Pubmed 29140105
  • Radiation oncology department, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM 1030, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Department of Radiology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Université Paris Sud, Université Paris Saclay, Faculté de médecine du Kremlin-Bicetre, Le Kremlin-Bicetre, France. · Pubmed 30304046
  • From the Department of Medical Oncology, Gustave Roussy, Villejuif, France (Dr Planchard) · and the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, (Dr Johnson). · Pubmed 29648886
  • Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Drug Development (DITEP), Gustave Roussy Institute, Villejuif, France. · Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: · Pubmed 29182990
2017
  • Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Carrer Sant Quintí 89, 08026, Barcelona, Spain. · Medical Oncology Department, Gustave Roussy, 114 rue Édouard Vaillant, 94805, Villejuif Cedex, France. · Pubmed 28589737
  • Drug Development Department, Institut Gustave Roussy, 114 rue Édouard-Vaillant, 94805 Villejuif Cedex, France; University Paris-Sud University, Orsay, France. Electronic address: · Mayo Clinic, 200 1st St. SW, Rochester, MN 55902, USA. Electronic address: · Drug Development Department, Institut Gustave Roussy, 114 rue Édouard-Vaillant, 94805 Villejuif Cedex, France. Electronic address: · Department of Medical Oncology, Institut Gustave Roussy, 114 rue Édouard-Vaillant, 94805, Villejuif Cedex, France. Electronic address: · Department of Head and Neck Oncology, Institut Gustave Roussy, 114 rue Édouard-Vaillant, 94805, Villejuif Cedex, France; Drug Development Department, Institut Gustave Roussy, 114 rue Édouard-Vaillant, 94805 Villejuif Cedex, France. Electronic address: · Department of Cancer Medicine, Institut Gustave Roussy, 114 rue Édouard-Vaillant, 94805, Villejuif Cedex, France. Electronic address: · Genentech, Inc., South San Francisco, CA, USA. Electronic address: · Genentech, Inc., South San Francisco, CA, USA. Electronic address: · Genentech, Inc., South San Francisco, CA, USA. Electronic address: · Genentech, Inc., South San Francisco, CA, USA. Electronic address: · Genentech, Inc., South San Francisco, CA, USA. Electronic address: · Genentech, Inc., South San Francisco, CA, USA. Electronic address: · Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, 14263, USA. Electronic address: · Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. Electronic address: · Pubmed 28992562
  • Gustave Roussy, Villejuif, France. · Vrije Universiteit VU Medical Centre, Amsterdam, Netherlands. · University of Groningen and University Medical Center Groningen, Groningen, Netherlands. · Rangueil-Larrey Hospital and Paul Sabatier University, Toulouse, France. · Oslo University Hospital, Department of Oncology, Norwegian Radium Hospital, Oslo, Norway. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Pubmed 28919011
  • Federica Grosso, Azienda Ospedaliera SS Antonio e Biagio General Hospital, Alessandria · Silvia Novello and Giorgio Scagliotti, L'università di Torino, Azienda Sanitaria Ospedale San Luigi Gonzaga, Turin, Italy · Anna K. Nowak, University of Western Australia, Crawley, and Sir Charles Gairdner Hospital, Nedlands, Western Australia · Thomas John, Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, Victoria, Australia · Sanjay Popat, The Royal Marsden Hospital National Health Service (NHS) Foundation Trust, London · Nicola Steele, The Beatson West of Scotland Cancer Centre, Glasgow · Paul Taylor, University Hospitals of South Manchester NHS Trust, Wythenshawe, Manchester, United Kingdom · Laurent Greillier, Assitance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille · David Planchard, Institut Gustave Roussy, Villejuif · Nassim Morsli, Boehringer Ingelheim France S.A.S., Paris, France · Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada · Martin Reck, Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf · Ute von Wangenheim, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany · Jens Benn Sørensen, Rigshospitalet - Finsencentret, Copenhagen, Denmark · Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL · Arsène Bienvenu Loembé, Boehringer Ingelheim B.V., Alkmaar, the Netherlands · and José Barrueco, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT. · Pubmed 28892431
  • James Chih-Hsin Yang and Chia-Chi Lin, National Taiwan University Hospital, Taipei · Wu-Chou Su, National Cheng Kung University Hospital, Tainan, Taiwan, Republic of China · Myung-Ju Ahn, Sungkyunkwan University · Dong-Wan Kim, Seoul National University Hospital · Sang-We Kim, Asan Medical Center, Seoul · Joo-Hang Kim, CHA University, Gyeonggi-do, Republic of Korea · Suresh S. Ramalingam, Emory University School of Medicine, Atlanta, GA · Lecia V. Sequist, Massachusetts General Hospital · Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, MA · David Planchard, Institut Gustave Roussy, Villejuif, France · Enriqueta Felip, Vall d'Hebron University Hospital, Barcelona, Spain · Fiona Blackhall, The Christie Hospital · University of Manchester, Manchester · Helen Mann and Serban Ghiorghiu, AstraZeneca, Cambridge · Mireille Cantarini, AstraZeneca, Macclesfield, United Kingdom · Daniel Haggstrom, Carolinas Healthcare System, Charlotte, NC · Kiyotaka Yoh, National Cancer Center Hospital East, Kashiwa, Chiba · Tomonori Hirashima, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Osaka, Japan · Silvia Novello, University of Turin, Turin, Italy · and Kathryn Gold, University of California San Diego Moores Cancer Center, San Diego, CA. · Pubmed 28221867
  • Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Radiology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Translational Research Laboratory, AMMICA, INSERM US23/CNRS UNS3655, Gustave Roussy, Villejuif, France. · Inivata Ltd, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. · Cambridge Cancer Centre, Cambridge, UK. · University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 28104619
  • Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France; Medical Oncology Unit, University Hospital of Parma, Parma, Italy. Electronic address: · Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: · Service de Biostatistique et Epidémiologie, Gustave Roussy Cancer Campus and INSERM U1018, Université Paris-Saclay, Villejuif, France. Electronic address: · Service de Biostatistique et Epidémiologie, Gustave Roussy Cancer Campus and INSERM U1018, Université Paris-Saclay, Villejuif, France. Electronic address: · Service de Biostatistique et Epidémiologie, Gustave Roussy Cancer Campus and INSERM U1018, Université Paris-Saclay, Villejuif, France. Electronic address: · Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: · Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: · INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France. Electronic address: · University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France; Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France; Genomic platform, Molecular Biopathology Unit and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655, University Paris XI, Gustave Roussy, Villejuif, France. Electronic address: · Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France. Electronic address: · Pubmed 29191602
  • Medical Oncology Department, Gustave Roussy, Villejuif, France. · Laboratory of Immunomonitoring in Oncology, CNRS-UMS 3655, INSERM-US23, Gustave Roussy, Villejuif, France. · Biostatistics and Epidemiology Department, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Biostatistics and Epidemiology Department, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Oncostat CESP, INSERM, Université Paris-Saclay, University Paris-Sud, UVSQ, Villejuif, France. · Drug Development Department, Gustave Roussy, Villejuif, France. · Radiology Deparment, Gustave Roussy, Villejuif, France. · Pathology Department, Gustave Roussy, Villejuif, France. · Drug Development Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · Laboratory of Immunomonitoring in Oncology, CNRS-UMS 3655, INSERM-US23, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Pharmacie, Chatenay-Malabry, France. · Medical Oncology Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. Electronic address: · Pubmed 29191581
  • Gustave Roussy, Department of Medical Oncology, 94805 Villejuif, France. Electronic address: · Pubmed 29056569
  • INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France. · Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 28633480
  • Département Interdisciplinaire de Soins de Support, Gustave-Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, F-94805, Villejuif, France. · Service de Biostatistique et d'Epidémiologie, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France. · Université Paris-Saclay, Univ. Paris-Sud, UVSQ, CESP, INSERM, F-94805, Villejuif, France. · Département d'Oncologie Médicale, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France. · Département Interdisciplinaire de Soins de Support, Gustave-Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, F-94805, Villejuif, France. · Département Ambulatoire, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France. · Pubmed 28593463
  • Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment," Villejuif, France. · Univ Paris Sud, Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicetre, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, Villejuif, France. · Univ Paris-Sud, Université Paris-Saclay, Faculty of Pharmacy, Châtenay-Malabry, France. · Gustave Roussy, Université Paris-Saclay, Department of Medicine, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France. · Pubmed 28461563
  • Radiation Oncology Department, Gustave Roussy, Villejuif, France. · Biopathology Department, Gustave Roussy, Villejuif, France. · Biostatistics and Epidemiolgy Unit, Villejuif, France. · Paris-Saclay University, Paris, France. · INSERM U1018, Villejuif, France. · Imaging Department, Gustave Roussy, Villejuif, France. · Medical Oncology Department, Gustave Roussy, Villejuif, France. · Pathology Department, Marie Lannelongue, Le Plessis Robinson, France. · Paris-Sud University, DHU TORINO, Paris, France. · INSERM U1030, Villejuif, France. · Pubmed 28445990
  • Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Villejuif, France; U1018 INSERM, CESP, Université Paris-Sud, Université Paris-Saclay, France. · Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: · Pubmed 28242503
2016
  • Medical Oncology Department, Gustave Roussy, Villejuif, France. · Medical Oncology Department, Gustave Roussy, 114 rue Édouard Vaillant, 94800 Villejuif, France · Pubmed 27784815
  • Medical Oncology Department, Gustave Roussy, 114 Rue Édouard Vaillant, 94805 Villejuif Cedex, France. · Pubmed 26892300
  • INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France. · Translational Research Laboratory and BioBank, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology and Laboratory Medicine (BIOpath), Gustave Roussy Cancer Campus, Villejuif, France. · Université Paris Saclay, Université Paris Sud, Faculté de médecine de Bicêtre, Kremlin-Bicêtre, France. · INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Sud, Villejuif, France. · Pubmed 27401242
  • Gustave Roussy, Villejuif, France. · Gustave Roussy, Villejuif, France; Paris-Sud University, Orsay, France. · University of Groningen, Groningen, Netherlands; University Medical Center Groningen, Groningen, the Netherlands. · Hopital Lyon Sud, Pierre-Bénite, France. · University Hospital, Nouvel Hôpital Civil, Strasbourg, France. · University of Washington, Seattle, WA, USA. · Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations Department, Hôpital Nord, Marseille, France. · Seoul National University Hospital, Seoul, South Korea. · Rangueil-Larrey Hospital, Toulouse, France; Paul Sabatier University, Toulouse, France. · Department of Oncology, University of Turin, Orbassano, Italy. · The Geisel School of Medicine at Dartmouth, Hanover, NH, USA. · Novartis Pharma AG, Postfach, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Pubmed 27283860
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address: · First Department of Internal Medicine, Kansai Medical University, Osaka, Japan. · Florida Cancer Specialists and Research Institute, Fort Myers, FL. · Department of Internal Medicine II, Lungenklinik Löwenstein GmbH, Löwenstein, Germany. · Department of Internal Medicine, Chonnam National University Medical School, Hwasun Hospital, Hwasun, Jeonnam, South Korea. · Global Medical Development (GMD), AstraZeneca, Gaithersburg, MD. · Biometrics and Information Sciences, AstraZeneca, Gaithersburg, MD. · DITEP (Département d'Innovations Thérapeutiques et Essais Précoces), Gustave Roussy, Villejuif, France. · Pubmed 27265743
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea. · Thoracic Oncology Unit, Rangueil-Larrey Hospital, Toulouse, France; Paul Sabatier University, Toulouse, France. · Pneumology Department, University Hospital of Strasbourg, Strasbourg, France. · Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Joan and Sanfor I Weill Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Multidisciplinary Oncology and Therapeutic Innovations Department, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Livon, Marseille, France. · Acute Respiratory Medicine and Thoracic Oncology Department, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Department of Pulmonary Diseases, Vrije Universiteit VU Medical Centre, Amsterdam, Netherlands. · Department of Pulmonary Diseases, University of Groningen, Groningen, Netherlands; University Medical Center Groningen, Groningen, Netherlands. · Upper Aerodigestive Malignancies Division, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. · College of Medicine, Yonsei University, Seoul, South Korea. · Lung Cancer Section, Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA, USA. · Adaptimmune LLC, Philadelphia, PA, USA. · GlaxoSmithKline, Collegeville, Pennsylvania, PA, USA. · Biothera, Eagan, MN, USA. · Novartis Pharmaceuticals, King of Prussia, PA, USA. · Novartis Pharmaceuticals, East Hanover, NJ, USA. · Novartis Pharmaceuticals, Morrisville, NC, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Pubmed 27080216
  • West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen German Cancer Research Center, German Cancer Consortium (DKTK), Heidelberg, Germany · Department of Medical Research, National Taiwan University and National Taiwan University Hospital, Taipei, Taiwan. · Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul. · Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. · Oncologie Médicale, Institut de Cancérologie de l'Ouest, Nantes, France. · Taipei Cancer Center, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. · Services de Pneumologie, CHI Créteil, Créteil, France. · 1st Oncological Pulmonary Unit, San Camillo, High Specialization Hospital, Rome Thoracic Oncology Division, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Jiangsu Province Cancer Hospital, Nanjing, China. · IRCCS AOU San Martino IST, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Lung Cancer, Seoul National University Hospital, Seoul, Republic of Korea. · Department of Pulmonary Oncology, Affiliated Hospital of Academy of Military Medical Science, Beijing. · Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. · Department of Pulmonology, Koranyi National Institute for Pulmonology, Budapest, Hungary. · Abdominal Department, Kharkiv Regional Clinical Oncology Center, Kharkiv, Ukraine. · Department of Medicine A, University Hospital, Münster, Germany. · Department of Oncology, Tongji University Medical School Cancer Institute, Shanghai, China. · Biostatistics, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield. · Clinical Development Medical Affairs-Oncology, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, USA. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Pubmed 26646759
  • Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif - France. · Medical Oncology Unit, University Hospital, Parma - Italy. · INSERM, U981, Gustave Roussy Cancer Campus, Villejuif - France. · Department of Medicine, University Paris-Sud, Kremlin Bicetre/Chatenay-Malabry - France. · Department of Radiology, Gustave Roussy Cancer Campus, Villejuif - France. · Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif - France. · Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif - France. · Pubmed 27197808
  • Hospices Civils de Lyon, Hôpital Edouard Herriot, Département d'Oncologie Médicale, 69437 Lyon cedex 03, France. Electronic address: · Gustave Roussy, Département d'Oncologie Médicale, 94805 Villejuif cedex, France. · Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Département de Pneumologie, Pierre-Bénite, France. · Gustave Roussy, Département de Biologie et Pathologie Médicales, 94805 Villejuif cedex, France. · Hospices Civils de Lyon, Hôpital Edouard Herriot, Département d'Oncologie Médicale, 69437 Lyon cedex 03, France. · Hospices Civils de Lyon, Hôpital Edouard Herriot, Service Central d'Anatomie et Cytologie Pathologiques, 69437 Lyon cedex 03, France. · Gustave Roussy, Département d'Oncologie Endocrinienne, 94805 Villejuif cedex, France. · L'Hôpital Nord-Ouest, Service de Pneumologie et d'Oncologie thoracique, 69655 Villefranche-sur-Saône, France. · Pubmed 27133753
  • Département de biologie et pathologie médicales, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Inserm U981, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France. Electronic address: · Département de biologie et pathologie médicales, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Département de médecine, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France. · DITEP Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Inserm U1015, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France. · Inserm U981, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; DITEP Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Faculté de médecine, université Paris Saclay, 63, rue Gabriel-Péri, 94276 Le Kremlin-Bicêtre cedex, France. · Département de biologie et pathologie médicales, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Faculté de médecine, université Paris Saclay, 63, rue Gabriel-Péri, 94276 Le Kremlin-Bicêtre cedex, France. · Département de biopathologie, MESOPATH, centre Léon-Bérard, 28, rue Laënnec, 69008 Lyon, France; Université Joseph-Fourier, Inserm U823, institut Albert-Bonniot, Grenoble, France. · Pubmed 26778219
  • West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany · Department of Medical Research, National Taiwan University and National Taiwan University Hospital, Taipei, Taiwan. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Pubmed 27029703
2015
  • Dept of Medical Oncology, Gustave Roussy, Villejuif, France · Dept of Medical Oncology, Gustave Roussy, Villejuif, France Paris-Sud University, Paris, France. · Pubmed 25931484
  • a INSERM, U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment" , F-94805 , VILLEJUIF , France. · b Gustave Roussy, Université Paris-Saclay , "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, F-94805 , VILLEJUIF , France. · c Department of Biopathology , Gustave Roussy , Villejuif , France. · d Department of Medicine , Gustave Roussy, F-94805 , Villejuif , France. · Pubmed 26564313
  • Gustave Roussy, Medical Oncology Department, Villejuif, France. · Pubmed 26450446
  • Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94800 Villejuif, France; CHU de Caen, pneumologie et oncologie thoracique, 14000 Caen, France. · Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94800 Villejuif, France; CHU Clermont-Ferrand, oncologie médicale, 63000 Clermont-Ferrand, France. · Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94800 Villejuif, France. · Institut Gustave-Roussy, département de médecine oncologique, 94800 Villejuif, France. · Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94800 Villejuif, France; Institut Gustave-Roussy, département de médecine oncologique, 94800 Villejuif, France; Université Paris-Sud, 91400 Orsay, France. Electronic address: · Pubmed 26235419
  • Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94805 Villejuif, France; CHU de Clermont-Ferrand, oncologie médicale, 63011 Clermont-Ferrand, France. · Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94805 Villejuif, France; CHU de Caen, pneumologie, 14033 Caen, France. · Institut Gustave-Roussy, département de médecine oncologique, 94805 Villejuif, France. · Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94805 Villejuif, France; Institut Gustave-Roussy, département de médecine oncologique, 94805 Villejuif, France; Université Paris-Sud, 75011 Paris, France. Electronic address: · Pubmed 25819217
  • From the Lowe Center for Thoracic Oncology and the Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston (P.A.J.) · National Taiwan University and National Taiwan University Hospital (J.C.-H.Y.) and Cheng Kung University Hospital (W.-C.S.) - both in Taipei, Taiwan · Seoul National University Hospital (D.-W.K.), Samsung Medical Center (M.-J.A.), Asan Medical Center (S.-W.K.), and Yonsei Cancer Center, Yonsei University Health System (J.-H.K.) - all in Seoul, South Korea · Institut Gustave Roussy, Villejuif, France (D.P.) · National Cancer Center Hospital, Tokyo (Y.O.) · Winship Cancer Institute of Emory University, Atlanta (S.S.R.) · Vanderbilt Ingram Cancer Center, Nashville (L.H.) · Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC (D.H.) · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona (E.F.) · and AstraZeneca, Macclesfield (P.F., M.C., K.H.B., P.A.D., S.G.), and University of Manchester, Christie Hospital, Manchester (M.R.) - both in the United Kingdom. · Pubmed 25923549
  • MD Anderson Cancer Center, The University of Texas, Houston, USA · Department of Pulmonary Diseases, Vrije Universiteit VU Medical Centre, Amsterdam, The Netherlands. · Medical Oncology Department, Gustave Roussy (GR), Villejuif, France. · Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. · Department of Respiratory Medicine, Hôpital Tenon, Assistance Publique - Hôpitaux de Paris, Paris, France. · European Institute of Oncology, Milan, Italy. · Duke University Medical Center, Durham, USA. · Korányi National Institute of Tuberculosis and Pulmonology, Budapest, Hungary. · Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. · IU Melvin and Bren Simon Cancer Center, Indianapolis, USA. · Yonsei Cancer Center, Division of Medical Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea. · Hopital Larrey CHU Toulouse, Toulouse, France. · Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · GlaxoSmithKline, Collegeville, USA. · GlaxoSmithKline Kft., Budapest, Hungary. · Lowe Center for Thoracic Oncology, Belfer Institute for Applied Cancer Science Dana-Farber Cancer Institute, Boston, USA. · Pubmed 25722381
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Electronic address: · Hôpital Larrey, Centre Hospitalier Universitaire de Toulouse, Toulouse, France. · L'Institut Gustave Roussy, Villejuif, France. · University of North Carolina School of Medicine, Chapel Hill, NC, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Centre Hospitalier Universitaire de Rennes, Rennes, France. · Ospedale S Maria, Terni, Italy. · Nouvel Hôpital Civil Chru de Strasbourg, Strasbourg, France. · The Ohio State University Medical Center, Columbus, OH, USA. · Oncology Consultants, PA, Houston, TX, USA. · University of California Davis Cancer Center, Sacramento, CA, USA. · Mount Sinai Beth Israel Comprehensive Cancer Center, New York, NY, USA. · Lehigh Valley Hospital, Allentown, PA, USA. · Centre Hospitalier Universitaire de Caen, Caen, France. · Universitaetsklinik Koeln, Koeln, Germany. · Hospices Civils de Lyon, Ch Lyon Sud, Pierre Benite, France. · Ospedale Campo Di Marte, Lucca, Italy. · Istituto Toscano Tumori, Livorno, Italy. · Chi De Creteil, Creteil, France. · University Hospitals of Cleveland, Cleveland, OH, USA. · Providence Portland Medical Center, Portland, OR, USA. · University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA. · Evangelische Lungenklinik Berlin, Berlin, Germany. · Klinikum der Universitaet Muenchen-Innenstadt, German Center for Lung Research, Munich, Germany. · Bristol-Myers Squibb, Princeton, NJ, USA. · Winship Cancer Institute, Emory University, Atlanta, GA, USA. · Pubmed 25704439
  • Department of Medical Oncology, Gustave Roussy, Villejuif · Department of Medical Oncology, Gustave Roussy, Villejuif. · Department of Medical Oncology, Gustave Roussy, Villejuif INSERM U981, Gustave Roussy, University Paris XI, Villejuif, France. · Drug Development Department (DITEP), Gustave Roussy, and University Paris-Sud, Villejuif. · Department of Medical Biology and Pathology. · Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif. · Drug Development Department (DITEP), Gustave Roussy, and University Paris-Sud, Villejuif INSERM U981, Gustave Roussy, University Paris XI, Villejuif, France. · Pubmed 26269204
  • INSERM U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", University of Paris-Sud XI, Gustave Roussy, Villejuif Translational Research Laboratory, Gustave Roussy, Villejuif. · Departments of Biopathology, Gustave Roussy, Villejuif, France. · INSERM U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", University of Paris-Sud XI, Gustave Roussy, Villejuif Translational Research Laboratory, Gustave Roussy, Villejuif Departments of Biopathology, Gustave Roussy, Villejuif, France. · Translational Research Laboratory, Gustave Roussy, Villejuif. · Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France. · Medicine, Gustave Roussy, Villejuif, France. · INSERM U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", University of Paris-Sud XI, Gustave Roussy, Villejuif Medicine, Gustave Roussy, Villejuif, France. · INSERM U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", University of Paris-Sud XI, Gustave Roussy, Villejuif Translational Research Laboratory, Gustave Roussy, Villejuif · Pubmed 25846554
  • Thoracic Group, INSERM U981, Gustave Roussy, Villejuif, France Faculty of Medicine, University of Toronto, Ontario, Canada. · Thoracic Group, INSERM U981, Gustave Roussy, Villejuif, France Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculty of Medicine, University of Toronto, Ontario, Canada. · Translational Research Laboratory, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France Pulmonary Department, Percy Hospital, Paris, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Pubmed 25519011
  • Drug Development Dept, Gustave Roussy Cancer Campus, University Paris-Sud, Villejuif, France. · Medical Oncology Dept, Gustave Roussy Cancer Campus, Villejuif, France. · Drug Development Dept, Gustave Roussy Cancer Campus, University Paris-Sud, Villejuif, France · Pubmed 25882801
2014
  • Thoracic Group, INSERM U981, Gustave Roussy, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France. · Drug Development Department, Gustave Roussy, Villejuif, France. · Thoracic Group, INSERM U981, Gustave Roussy, Villejuif, France; Drug Development Department, Gustave Roussy, Villejuif, France. · Drug Development Department, Gustave Roussy, Villejuif, France; Pulmonary Department, Percy Hospital, Paris, France. · Pubmed 24882384
  • CHITS Toulon, Hôpital de Toulon, Service de pneumologie, 54, rue Sainte-Claire-Deville, 83056 Toulon, France. · Université Claude-Bernard Lyon 1, Hospices civils de Lyon, Hôpital Louis-Pradel, Service de pneumologie, 69677 Lyon, France. · Université Lille Nord de France, CHRU de Lille, Service de pneumologie et oncologie thoracique, 59000 Lille, France. · Nouvel Hôpital civil, Service de pneumologie, 67091 Strasbourg, France. · Hôpital de Mulhouse, Service de pneumologie, 68100 Mulhouse, France. · Gustave-Roussy, Service d'oncologie médicale, 94805 Villejuif, France. · CHU Côte-de-Nacre, Service de pneumologie et oncologie thoracique, 14033 Caen, France. · CHRU de Grenoble, Hôpital Michallon, Service de pneumologie, 38043 Grenoble, France. · AP-HP, Hôpital Tenon, Service de pneumologie et Sorbonne Universités, UPMC Univ 75006 Paris 06 - GRC n̊ 04, Theranoscan 75970 Paris, France. · AP-HP Marseille, Université Aix-Marseille, Service d'oncologie multidisciplinaire & innovations thérapeutiques, 13015 Marseille, France. · Pubmed 25299566
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department of Medical Oncology, University Hospital, Udine, Italy. Electronic address: · Department of Radiology, Gustave Roussy, Villejuif, France. · Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department of Second Medical Oncology, Oncologic Venetian Institute, Padua, Italy. · Translational Research Laboratory, Gustave Roussy, Villejuif, France. · Pubmed 24439569
2013
  • Department of Medical Oncology (Thoracic Unit), Institut-Gustave-Roussy, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France. · Pubmed 23371030
2012
  • French Institute of Health and Medical Research U981 Thoracic Unit, Gustave Roussy Institute, Villejuif, France. · Pubmed 22415779
2011
  • Medical Oncology Department, Institut Gustave Roussy, Villejuif, France. · Pubmed 21943984
  • Département de Médecine, Institut Gustave Roussy, Villejuif, France. · Pubmed 21916570
  • Département d'oncologie médicale, institut Gustave Roussy, 114, rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 21777766
2010
  • Unité Inserm U981, institut Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France. · Pubmed 20403548
2009
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 19995647
  • Institut Gustave-Roussy, Département de médecine, 39, rue Camille-Desmoulins, 94805 Villejuif, France. · Pubmed 20034871
  • Medical Oncology and Translational Research, Institut de Cancérologie Gustave Roussy,Villejuif, France. · Pubmed 19297315
2018
  • From the Department of Medicine, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center, Nashville, TN. · Pubmed 30231382
  • From the H. Lee Moffitt Cancer Center and Research Institute, Tampa (S.J.A., A.C., J.E.G.), Cancer Specialists of North Florida, Jacksonville (A.V.), Florida Cancer Specialists, Fleming Island (A.V.), and Florida Hospital Cancer Institute, Orlando (T.M.) - all in Florida · Tennessee Oncology, Chattanooga (D.D.), and Sarah Cannon Research Institute, Nashville (D.D., D.R.S.) - both in Tennessee · Hospital Universitario Virgen Macarena, Seville (D.V.), and Hospital Universitario 12 de Octubre, CiberOnc, Universidad Complutense and Spanish National Cancer Research Center (L.P.-A.), and Hospital Universitario La Paz (J.C.C.), Madrid - all in Spain · Kanagawa Cancer Center, Yokohama (S.M.), Kansai Medical University Hospital, Hirakata (T.K.), Kurume University Hospital, Kurume (T.T.), and Nippon Medical School Hospital, Tokyo (K.K.) - all in Japan · Westmead Hospital and the University of Sydney, Sydney (R.H.), and Flinders University and Flinders Medical Centre, Adelaide, SA (C.S.K.) - all in Australia · Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju (K.H.L.), Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju (Y.-C.K.) - all in South Korea · Vivantes Klinikum Neukoelln, Berlin (M.W.), and the Lung Clinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf (M.R.) - both in Germany · Centre Hospitalier Universitaire de Liège, Liège (M.B.), and University Hospitals KU Leuven, Leuven (J.V.) - both in Belgium · Centre Hospitalier Universitaire de Montpellier and Institut du Cancer de Montpellier Val d'Aurelle, Montpellier (X.Q.), Institut Gustave Roussy, Villejuif (D.P.), and Institut de Cancérologie de l'Ouest-site René Gauducheau, Saint Herblain (S.H.) - all in France · National Koranyi Institute of Pulmonology, Budapest, Hungary (G.O.) · the University of Manchester and the Christie NHS Foundation Trust, Manchester (C.F.-F.), AstraZeneca, Alderley Park (C.W.), and AstraZeneca, Cambridge (M.T.) - all in the United Kingdom · AstraZeneca, Gaithersburg, MD (G.M., P.A.D.) · and Istanbul University-Cerrahpasa, Cerrahpasa School of Medicine, Istanbul, Turkey (M.Ö.). · Pubmed 30280658
2017
  • From the Department of Oncology Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Department of Oncology Medicine, Hospital de la Vall d'Hebron, Barcelona, Spain; Institut National du Cancer, Boulogne-Billancourt, France; University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 28561640
  • From the H. Lee Moffitt Cancer Center and Research Institute, Tampa (S.J.A., A.C., J.E.G.), Cancer Specialists of North Florida, Jacksonville (A.V.), and Florida Hospital Cancer Institute, Orlando (T.M.) - all in Florida · Tennessee Oncology, Chattanooga, and Sarah Cannon Research Institute, Nashville - both in Tennessee (D.D.) · Hospital Universitario Virgen Macarena, Seville (D.V.), and Hospital Universitario 12 de Octubre, Centro de Investigación Biomédica en Red de Cáncer, Universidad Complutense and the Spanish National Cancer Research Center (L.P.-A.), and Hospital Universitario La Paz (J.C.C.), Madrid - all in Spain · Kanagawa Cancer Center, Yokohama (S.M.), Kansai Medical University Hospital, Hirakata (T.Y.), Kurume University Hospital, Kurume (T.T.), and Nippon Medical School Hospital, Tokyo (K.K.) - all in Japan · Westmead Hospital and the University of Sydney, Sydney (R.H.), and Flinders University and Flinders Medical Centre, Bedford Park, SA (C.S.K.) - all in Australia · Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju (K.H.L.), Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju (Y.-C.K.) - all in South Korea · Vivantes Klinikum Neukölln, Berlin (M.W.) · Centre Hospitalier Universitaire de Liège, Liège, Belgium (M.B.) · Centre Hospitalier Universitaire Montpellier and Cancer Institute of Montpellier Val d'Aurelle, Montpellier (X.Q.), Institut Gustave Roussy, Villejuif (D.P.), and Institut de Cancérologie de l'Ouest-Site René Gauducheau, Saint Herblain (S.H.) - all in France · National Koranyi Institute of Pulmonology, Budapest, Hungary (G.O.) · AstraZeneca, Alderley Park, United Kingdom (C.W.) · AstraZeneca, Gaithersburg, MD (G.M., H.J., Y.H., P.A.D.) · and Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey (M.Ö.). · Pubmed 28885881
2016
  • aMedical Oncology DepartmentbLaboratoire d'immunomonitoring en Oncologie UMS 3655 CNRS/US 23 INSERM, Gustave Roussy, Villejuif, France. · Pubmed 26756384
2015
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Pubmed 26001149
2013
  • Service des urgences, CLAN institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif cedex, France. · Pubmed 23835321
  • SITEP (Service des Innovations Therapeutiques Precoces), Department of Medicine, Institut Gustave Roussy, Paris XI University, Villejuif, France. · Pubmed 23774150
  • Institut de Cancérologie Gustave Roussy, Villejuif, France. · Pubmed 23669222
2012
  • Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France. · Pubmed 23582924
  • Département de Médecine, Institut Gustave Roussy, Villejuif, France. · Pubmed 22186627
  • Departments of Medicine and Biostatistics, Institut Gustave Roussy, Villejuif, France. · Pubmed 22617247
2011
  • Institut Gustave-Roussy, université Paris-Sud, Inserm U, Villejuif, France. · Pubmed 21459711
  • Institut Gustave-Roussy, département de médecine, 94805 Villejuif, France. · Pubmed 21420271
  • University of Paris-Sud, INSERM U981 'Identification of molecular predictors and new targets for cancer treatment', Institut de Cancérologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 21970878
2010
  • Département de médecine, Institut Gustave-Roussy, 94805 Villejuif. · Pubmed 20225562
  • Department of Medicine, Biostatistics and Epidemiology Unit, Translational Research Laboratory, Paris-Sud University, Gustave-Roussy Institute, Villejuif, France. · Pubmed 20145178
Probable:    Universite Paris-Saclay      
2018
  • Radiation oncology department, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM 1030, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Department of Radiology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Université Paris Sud, Université Paris Saclay, Faculté de médecine du Kremlin-Bicetre, Le Kremlin-Bicetre, France. · Pubmed 30304046
2017
  • Département Interdisciplinaire de Soins de Support, Gustave-Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, F-94805, Villejuif, France. · Service de Biostatistique et d'Epidémiologie, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France. · Université Paris-Saclay, Univ. Paris-Sud, UVSQ, CESP, INSERM, F-94805, Villejuif, France. · Département d'Oncologie Médicale, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France. · Département Interdisciplinaire de Soins de Support, Gustave-Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, F-94805, Villejuif, France. · Département Ambulatoire, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France. · Pubmed 28593463
  • Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment," Villejuif, France. · Univ Paris Sud, Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicetre, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, Villejuif, France. · Univ Paris-Sud, Université Paris-Saclay, Faculty of Pharmacy, Châtenay-Malabry, France. · Gustave Roussy, Université Paris-Saclay, Department of Medicine, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France. · Pubmed 28461563
2017
  • From the Department of Oncology Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Department of Oncology Medicine, Hospital de la Vall d'Hebron, Barcelona, Spain; Institut National du Cancer, Boulogne-Billancourt, France; University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 28561640
Probable:    Universite Paris 11 Sud      
2018
  • From Gustave Roussy Cancer Campus and University Paris-Sud, Orsay, France (J.-C.S., D.P.) · the Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo (Y.O.), the Department of Thoracic Oncology, Osaka International Cancer Institute (F.I.), and the Department of Thoracic Oncology, Kansai Medical University Hospital (T.K.), Osaka, the Department of Thoracic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama (N.N.), and the Research Institute for Diseases of the Chest, Graduate School of Medical Science, Kyushu University, Fukuoka (I.O.) - all in Japan · the Respiratory Oncology Unit, University Hospital KU Leuven, Leuven, Belgium (J.V.) · Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok (T.R.), the Oncology Unit, Department of Medicine, Chiang Mai University, Chiang Mai (B.C.), and the Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai (A.D.) - all in Thailand · the Division of Medical Oncology, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheong-ju (K.H.L.), the Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and the Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon (E.K.C.) - all in South Korea · Pulmonary Hospital of Tongji University, Shanghai (C.Z.), and Jilin Provincial Cancer Hospital, Changchun (Y.C.) - both in China · Hospital Umum Sarawak, Kuching, Malaysia (P.J.V.) · National Cheng Kung University, Tainan, Taiwan (W.-C.S.) · the Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (J.E.G.) · the Department of Oncology, University College London Hospitals Biomedical Research Centre, and the Cancer Research UK Lung Cancer Centre of Excellence, London (S.-M.L.), and AstraZeneca, Cambridge (R.H., M.M., Y.R.) - all in the United Kingdom · and Emory University School of Medicine, Winship Cancer Institute, Atlanta (S.S.R.). · Pubmed 29151359
2017
  • From the Department of Oncology Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Department of Oncology Medicine, Hospital de la Vall d'Hebron, Barcelona, Spain; Institut National du Cancer, Boulogne-Billancourt, France; University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 28561640
2013
  • SITEP (Service des Innovations Therapeutiques Precoces), Department of Medicine, Institut Gustave Roussy, Paris XI University, Villejuif, France. · Pubmed 23774150
2011
  • Institut Gustave-Roussy, université Paris-Sud, Inserm U, Villejuif, France. · Pubmed 21459711
  • University of Paris-Sud, INSERM U981 'Identification of molecular predictors and new targets for cancer treatment', Institut de Cancérologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 21970878
2010
  • Department of Medicine, Biostatistics and Epidemiology Unit, Translational Research Laboratory, Paris-Sud University, Gustave-Roussy Institute, Villejuif, France. · Pubmed 20145178
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 80 total) written by David Planchard about Lung Neoplasms:

  • Safety of osimertinib in EGFR-mutated non-small cell lung cancer. 2018
  • Sequencing Therapy for Genetically Defined Subgroups of Non-Small Cell Lung Cancer. 2018
  • Durvalumab for the treatment of non-small cell lung cancer. 2018
  • BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall. 2018
  • Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology. 2018
  • Durvalumab in non-small-cell lung cancer patients: current developments. 2018
  • Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC. 2018
  • Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer. 2018
  • Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer. 2018
  • BRAF Adds an Additional Piece of the Puzzle to Precision Oncology-Based Treatment Strategies in Lung Cancer. 2018
Show List of Full Article Records
Google Searches

Learn more about David Planchard using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Institut Gustave Roussy
Universite Paris-Saclay
Universite Paris 11 Sud
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Institut Gustave Roussy
2018
  • a Medical Oncology Department , Gustave Roussy , Villejuif , France. · b Early Drug Development Department , Gustave Roussy , Villejuif , France. · Pubmed 30457891
  • a Medical Oncology Department , Gustave Roussy , Villejuif , France. · Pubmed 29958099
  • Medical Oncology Unit, University Hospital of Parma, Parma, Italy. · Pathology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy. · Medical Illustrator, Riccione, Italy. · INSERM, U981, Gustave Roussy Cancer Campus, Villejuif, France. · Medical Oncology Unit, University Hospital of Parma, Parma, Italy. Electronic address: · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 29729495
  • Division of Medical Oncology, "S.G. Moscati" Hospital, Avellino, Italy. Electronic address: · Department of Thoracic Oncology, The Netherlands Cancer Institute, The Academic Medical Center, Amsterdam, The Netherlands. · Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille, France. · Department of Medical Oncology, Second University of Naples, Naples, Italy. · Department of Oncology, Istituto Scientifico Romagnolo per lo studio e la Ricerca dei tumori, IRCCS, Meldola, Italy. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI. · Department of Thoracic/Head and Neck Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX. · Hospital Universitario 12 de Octubre, CNIO, Universidad Complutense, Madrid, Spain. · Department of Cancer Medicine Thoracic Unit, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Cancer Research Centre Léon Bérard and Claude Bernard University, Lyon, France. · Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indiana University, Indianapolis, IN. · Division of Medical Oncology, "S.G. Moscati" Hospital, Avellino, Italy. · Thoracic Division, Medical Oncology Department, European Institute of Oncology, Milan, Italy. · Pubmed 29396237
  • Medical Oncology Department, Gustave Roussy, Villejuif, France. · Pubmed 29140105
  • Radiation oncology department, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM 1030, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Department of Radiology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Université Paris Sud, Université Paris Saclay, Faculté de médecine du Kremlin-Bicetre, Le Kremlin-Bicetre, France. · Pubmed 30304046
  • From the Department of Medical Oncology, Gustave Roussy, Villejuif, France (Dr Planchard) · and the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, (Dr Johnson). · Pubmed 29648886
  • Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Drug Development (DITEP), Gustave Roussy Institute, Villejuif, France. · Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: · Pubmed 29182990
2017
  • Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Carrer Sant Quintí 89, 08026, Barcelona, Spain. · Medical Oncology Department, Gustave Roussy, 114 rue Édouard Vaillant, 94805, Villejuif Cedex, France. · Pubmed 28589737
  • Drug Development Department, Institut Gustave Roussy, 114 rue Édouard-Vaillant, 94805 Villejuif Cedex, France; University Paris-Sud University, Orsay, France. Electronic address: · Mayo Clinic, 200 1st St. SW, Rochester, MN 55902, USA. Electronic address: · Drug Development Department, Institut Gustave Roussy, 114 rue Édouard-Vaillant, 94805 Villejuif Cedex, France. Electronic address: · Department of Medical Oncology, Institut Gustave Roussy, 114 rue Édouard-Vaillant, 94805, Villejuif Cedex, France. Electronic address: · Department of Head and Neck Oncology, Institut Gustave Roussy, 114 rue Édouard-Vaillant, 94805, Villejuif Cedex, France; Drug Development Department, Institut Gustave Roussy, 114 rue Édouard-Vaillant, 94805 Villejuif Cedex, France. Electronic address: · Department of Cancer Medicine, Institut Gustave Roussy, 114 rue Édouard-Vaillant, 94805, Villejuif Cedex, France. Electronic address: · Genentech, Inc., South San Francisco, CA, USA. Electronic address: · Genentech, Inc., South San Francisco, CA, USA. Electronic address: · Genentech, Inc., South San Francisco, CA, USA. Electronic address: · Genentech, Inc., South San Francisco, CA, USA. Electronic address: · Genentech, Inc., South San Francisco, CA, USA. Electronic address: · Genentech, Inc., South San Francisco, CA, USA. Electronic address: · Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, 14263, USA. Electronic address: · Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. Electronic address: · Pubmed 28992562
  • Gustave Roussy, Villejuif, France. · Vrije Universiteit VU Medical Centre, Amsterdam, Netherlands. · University of Groningen and University Medical Center Groningen, Groningen, Netherlands. · Rangueil-Larrey Hospital and Paul Sabatier University, Toulouse, France. · Oslo University Hospital, Department of Oncology, Norwegian Radium Hospital, Oslo, Norway. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Pubmed 28919011
  • Federica Grosso, Azienda Ospedaliera SS Antonio e Biagio General Hospital, Alessandria · Silvia Novello and Giorgio Scagliotti, L'università di Torino, Azienda Sanitaria Ospedale San Luigi Gonzaga, Turin, Italy · Anna K. Nowak, University of Western Australia, Crawley, and Sir Charles Gairdner Hospital, Nedlands, Western Australia · Thomas John, Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, Victoria, Australia · Sanjay Popat, The Royal Marsden Hospital National Health Service (NHS) Foundation Trust, London · Nicola Steele, The Beatson West of Scotland Cancer Centre, Glasgow · Paul Taylor, University Hospitals of South Manchester NHS Trust, Wythenshawe, Manchester, United Kingdom · Laurent Greillier, Assitance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille · David Planchard, Institut Gustave Roussy, Villejuif · Nassim Morsli, Boehringer Ingelheim France S.A.S., Paris, France · Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada · Martin Reck, Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf · Ute von Wangenheim, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany · Jens Benn Sørensen, Rigshospitalet - Finsencentret, Copenhagen, Denmark · Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL · Arsène Bienvenu Loembé, Boehringer Ingelheim B.V., Alkmaar, the Netherlands · and José Barrueco, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT. · Pubmed 28892431
  • James Chih-Hsin Yang and Chia-Chi Lin, National Taiwan University Hospital, Taipei · Wu-Chou Su, National Cheng Kung University Hospital, Tainan, Taiwan, Republic of China · Myung-Ju Ahn, Sungkyunkwan University · Dong-Wan Kim, Seoul National University Hospital · Sang-We Kim, Asan Medical Center, Seoul · Joo-Hang Kim, CHA University, Gyeonggi-do, Republic of Korea · Suresh S. Ramalingam, Emory University School of Medicine, Atlanta, GA · Lecia V. Sequist, Massachusetts General Hospital · Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, MA · David Planchard, Institut Gustave Roussy, Villejuif, France · Enriqueta Felip, Vall d'Hebron University Hospital, Barcelona, Spain · Fiona Blackhall, The Christie Hospital · University of Manchester, Manchester · Helen Mann and Serban Ghiorghiu, AstraZeneca, Cambridge · Mireille Cantarini, AstraZeneca, Macclesfield, United Kingdom · Daniel Haggstrom, Carolinas Healthcare System, Charlotte, NC · Kiyotaka Yoh, National Cancer Center Hospital East, Kashiwa, Chiba · Tomonori Hirashima, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Osaka, Japan · Silvia Novello, University of Turin, Turin, Italy · and Kathryn Gold, University of California San Diego Moores Cancer Center, San Diego, CA. · Pubmed 28221867
  • Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Radiology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Translational Research Laboratory, AMMICA, INSERM US23/CNRS UNS3655, Gustave Roussy, Villejuif, France. · Inivata Ltd, Cambridge, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. · Cambridge Cancer Centre, Cambridge, UK. · University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 28104619
  • Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France; INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France; Medical Oncology Unit, University Hospital of Parma, Parma, Italy. Electronic address: · Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: · Service de Biostatistique et Epidémiologie, Gustave Roussy Cancer Campus and INSERM U1018, Université Paris-Saclay, Villejuif, France. Electronic address: · Service de Biostatistique et Epidémiologie, Gustave Roussy Cancer Campus and INSERM U1018, Université Paris-Saclay, Villejuif, France. Electronic address: · Service de Biostatistique et Epidémiologie, Gustave Roussy Cancer Campus and INSERM U1018, Université Paris-Saclay, Villejuif, France. Electronic address: · Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: · Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: · INSERM U981, Gustave Roussy Cancer Campus, Villejuif, France; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France. Electronic address: · University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France; Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France; Genomic platform, Molecular Biopathology Unit and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655, University Paris XI, Gustave Roussy, Villejuif, France. Electronic address: · Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Sud Kremlin Bicetre/Chatenay-Malabry, Le Kremlin-Bicêtre, France. Electronic address: · Pubmed 29191602
  • Medical Oncology Department, Gustave Roussy, Villejuif, France. · Laboratory of Immunomonitoring in Oncology, CNRS-UMS 3655, INSERM-US23, Gustave Roussy, Villejuif, France. · Biostatistics and Epidemiology Department, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Biostatistics and Epidemiology Department, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Oncostat CESP, INSERM, Université Paris-Saclay, University Paris-Sud, UVSQ, Villejuif, France. · Drug Development Department, Gustave Roussy, Villejuif, France. · Radiology Deparment, Gustave Roussy, Villejuif, France. · Pathology Department, Gustave Roussy, Villejuif, France. · Drug Development Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · Laboratory of Immunomonitoring in Oncology, CNRS-UMS 3655, INSERM-US23, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Pharmacie, Chatenay-Malabry, France. · Medical Oncology Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. Electronic address: · Pubmed 29191581
  • Gustave Roussy, Department of Medical Oncology, 94805 Villejuif, France. Electronic address: · Pubmed 29056569
  • INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France. · Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 28633480
  • Département Interdisciplinaire de Soins de Support, Gustave-Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, F-94805, Villejuif, France. · Service de Biostatistique et d'Epidémiologie, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France. · Université Paris-Saclay, Univ. Paris-Sud, UVSQ, CESP, INSERM, F-94805, Villejuif, France. · Département d'Oncologie Médicale, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France. · Département Interdisciplinaire de Soins de Support, Gustave-Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, F-94805, Villejuif, France. · Département Ambulatoire, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France. · Pubmed 28593463
  • Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment," Villejuif, France. · Univ Paris Sud, Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicetre, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, Villejuif, France. · Univ Paris-Sud, Université Paris-Saclay, Faculty of Pharmacy, Châtenay-Malabry, France. · Gustave Roussy, Université Paris-Saclay, Department of Medicine, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France. · Pubmed 28461563
  • Radiation Oncology Department, Gustave Roussy, Villejuif, France. · Biopathology Department, Gustave Roussy, Villejuif, France. · Biostatistics and Epidemiolgy Unit, Villejuif, France. · Paris-Saclay University, Paris, France. · INSERM U1018, Villejuif, France. · Imaging Department, Gustave Roussy, Villejuif, France. · Medical Oncology Department, Gustave Roussy, Villejuif, France. · Pathology Department, Marie Lannelongue, Le Plessis Robinson, France. · Paris-Sud University, DHU TORINO, Paris, France. · INSERM U1030, Villejuif, France. · Pubmed 28445990
  • Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Villejuif, France; U1018 INSERM, CESP, Université Paris-Sud, Université Paris-Saclay, France. · Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: · Pubmed 28242503
2016
  • Medical Oncology Department, Gustave Roussy, Villejuif, France. · Medical Oncology Department, Gustave Roussy, 114 rue Édouard Vaillant, 94800 Villejuif, France · Pubmed 27784815
  • Medical Oncology Department, Gustave Roussy, 114 Rue Édouard Vaillant, 94805 Villejuif Cedex, France. · Pubmed 26892300
  • INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France. · Translational Research Laboratory and BioBank, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology and Laboratory Medicine (BIOpath), Gustave Roussy Cancer Campus, Villejuif, France. · Université Paris Saclay, Université Paris Sud, Faculté de médecine de Bicêtre, Kremlin-Bicêtre, France. · INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Sud, Villejuif, France. · Pubmed 27401242
  • Gustave Roussy, Villejuif, France. · Gustave Roussy, Villejuif, France; Paris-Sud University, Orsay, France. · University of Groningen, Groningen, Netherlands; University Medical Center Groningen, Groningen, the Netherlands. · Hopital Lyon Sud, Pierre-Bénite, France. · University Hospital, Nouvel Hôpital Civil, Strasbourg, France. · University of Washington, Seattle, WA, USA. · Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations Department, Hôpital Nord, Marseille, France. · Seoul National University Hospital, Seoul, South Korea. · Rangueil-Larrey Hospital, Toulouse, France; Paul Sabatier University, Toulouse, France. · Department of Oncology, University of Turin, Orbassano, Italy. · The Geisel School of Medicine at Dartmouth, Hanover, NH, USA. · Novartis Pharma AG, Postfach, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Pubmed 27283860
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address: · First Department of Internal Medicine, Kansai Medical University, Osaka, Japan. · Florida Cancer Specialists and Research Institute, Fort Myers, FL. · Department of Internal Medicine II, Lungenklinik Löwenstein GmbH, Löwenstein, Germany. · Department of Internal Medicine, Chonnam National University Medical School, Hwasun Hospital, Hwasun, Jeonnam, South Korea. · Global Medical Development (GMD), AstraZeneca, Gaithersburg, MD. · Biometrics and Information Sciences, AstraZeneca, Gaithersburg, MD. · DITEP (Département d'Innovations Thérapeutiques et Essais Précoces), Gustave Roussy, Villejuif, France. · Pubmed 27265743
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea. · Thoracic Oncology Unit, Rangueil-Larrey Hospital, Toulouse, France; Paul Sabatier University, Toulouse, France. · Pneumology Department, University Hospital of Strasbourg, Strasbourg, France. · Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Joan and Sanfor I Weill Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Multidisciplinary Oncology and Therapeutic Innovations Department, Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Livon, Marseille, France. · Acute Respiratory Medicine and Thoracic Oncology Department, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Department of Pulmonary Diseases, Vrije Universiteit VU Medical Centre, Amsterdam, Netherlands. · Department of Pulmonary Diseases, University of Groningen, Groningen, Netherlands; University Medical Center Groningen, Groningen, Netherlands. · Upper Aerodigestive Malignancies Division, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. · College of Medicine, Yonsei University, Seoul, South Korea. · Lung Cancer Section, Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA, USA. · Adaptimmune LLC, Philadelphia, PA, USA. · GlaxoSmithKline, Collegeville, Pennsylvania, PA, USA. · Biothera, Eagan, MN, USA. · Novartis Pharmaceuticals, King of Prussia, PA, USA. · Novartis Pharmaceuticals, East Hanover, NJ, USA. · Novartis Pharmaceuticals, Morrisville, NC, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Pubmed 27080216
  • West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen German Cancer Research Center, German Cancer Consortium (DKTK), Heidelberg, Germany · Department of Medical Research, National Taiwan University and National Taiwan University Hospital, Taipei, Taiwan. · Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul. · Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. · Oncologie Médicale, Institut de Cancérologie de l'Ouest, Nantes, France. · Taipei Cancer Center, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. · Services de Pneumologie, CHI Créteil, Créteil, France. · 1st Oncological Pulmonary Unit, San Camillo, High Specialization Hospital, Rome Thoracic Oncology Division, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Jiangsu Province Cancer Hospital, Nanjing, China. · IRCCS AOU San Martino IST, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Lung Cancer, Seoul National University Hospital, Seoul, Republic of Korea. · Department of Pulmonary Oncology, Affiliated Hospital of Academy of Military Medical Science, Beijing. · Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China. · Department of Pulmonology, Koranyi National Institute for Pulmonology, Budapest, Hungary. · Abdominal Department, Kharkiv Regional Clinical Oncology Center, Kharkiv, Ukraine. · Department of Medicine A, University Hospital, Münster, Germany. · Department of Oncology, Tongji University Medical School Cancer Institute, Shanghai, China. · Biostatistics, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield. · Clinical Development Medical Affairs-Oncology, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, USA. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Pubmed 26646759
  • Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif - France. · Medical Oncology Unit, University Hospital, Parma - Italy. · INSERM, U981, Gustave Roussy Cancer Campus, Villejuif - France. · Department of Medicine, University Paris-Sud, Kremlin Bicetre/Chatenay-Malabry - France. · Department of Radiology, Gustave Roussy Cancer Campus, Villejuif - France. · Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif - France. · Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif - France. · Pubmed 27197808
  • Hospices Civils de Lyon, Hôpital Edouard Herriot, Département d'Oncologie Médicale, 69437 Lyon cedex 03, France. Electronic address: · Gustave Roussy, Département d'Oncologie Médicale, 94805 Villejuif cedex, France. · Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Département de Pneumologie, Pierre-Bénite, France. · Gustave Roussy, Département de Biologie et Pathologie Médicales, 94805 Villejuif cedex, France. · Hospices Civils de Lyon, Hôpital Edouard Herriot, Département d'Oncologie Médicale, 69437 Lyon cedex 03, France. · Hospices Civils de Lyon, Hôpital Edouard Herriot, Service Central d'Anatomie et Cytologie Pathologiques, 69437 Lyon cedex 03, France. · Gustave Roussy, Département d'Oncologie Endocrinienne, 94805 Villejuif cedex, France. · L'Hôpital Nord-Ouest, Service de Pneumologie et d'Oncologie thoracique, 69655 Villefranche-sur-Saône, France. · Pubmed 27133753
  • Département de biologie et pathologie médicales, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Inserm U981, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France. Electronic address: · Département de biologie et pathologie médicales, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Département de médecine, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France. · DITEP Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Inserm U1015, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France. · Inserm U981, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; DITEP Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Faculté de médecine, université Paris Saclay, 63, rue Gabriel-Péri, 94276 Le Kremlin-Bicêtre cedex, France. · Département de biologie et pathologie médicales, Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Faculté de médecine, université Paris Saclay, 63, rue Gabriel-Péri, 94276 Le Kremlin-Bicêtre cedex, France. · Département de biopathologie, MESOPATH, centre Léon-Bérard, 28, rue Laënnec, 69008 Lyon, France; Université Joseph-Fourier, Inserm U823, institut Albert-Bonniot, Grenoble, France. · Pubmed 26778219
  • West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany · Department of Medical Research, National Taiwan University and National Taiwan University Hospital, Taipei, Taiwan. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Pubmed 27029703
2015
  • Dept of Medical Oncology, Gustave Roussy, Villejuif, France · Dept of Medical Oncology, Gustave Roussy, Villejuif, France Paris-Sud University, Paris, France. · Pubmed 25931484
  • a INSERM, U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment" , F-94805 , VILLEJUIF , France. · b Gustave Roussy, Université Paris-Saclay , "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, F-94805 , VILLEJUIF , France. · c Department of Biopathology , Gustave Roussy , Villejuif , France. · d Department of Medicine , Gustave Roussy, F-94805 , Villejuif , France. · Pubmed 26564313
  • Gustave Roussy, Medical Oncology Department, Villejuif, France. · Pubmed 26450446
  • Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94800 Villejuif, France; CHU de Caen, pneumologie et oncologie thoracique, 14000 Caen, France. · Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94800 Villejuif, France; CHU Clermont-Ferrand, oncologie médicale, 63000 Clermont-Ferrand, France. · Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94800 Villejuif, France. · Institut Gustave-Roussy, département de médecine oncologique, 94800 Villejuif, France. · Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94800 Villejuif, France; Institut Gustave-Roussy, département de médecine oncologique, 94800 Villejuif, France; Université Paris-Sud, 91400 Orsay, France. Electronic address: · Pubmed 26235419
  • Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94805 Villejuif, France; CHU de Clermont-Ferrand, oncologie médicale, 63011 Clermont-Ferrand, France. · Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94805 Villejuif, France; CHU de Caen, pneumologie, 14033 Caen, France. · Institut Gustave-Roussy, département de médecine oncologique, 94805 Villejuif, France. · Institut Gustave-Roussy, département d'innovation thérapeutique et d'essais précoces, 94805 Villejuif, France; Institut Gustave-Roussy, département de médecine oncologique, 94805 Villejuif, France; Université Paris-Sud, 75011 Paris, France. Electronic address: · Pubmed 25819217
  • From the Lowe Center for Thoracic Oncology and the Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston (P.A.J.) · National Taiwan University and National Taiwan University Hospital (J.C.-H.Y.) and Cheng Kung University Hospital (W.-C.S.) - both in Taipei, Taiwan · Seoul National University Hospital (D.-W.K.), Samsung Medical Center (M.-J.A.), Asan Medical Center (S.-W.K.), and Yonsei Cancer Center, Yonsei University Health System (J.-H.K.) - all in Seoul, South Korea · Institut Gustave Roussy, Villejuif, France (D.P.) · National Cancer Center Hospital, Tokyo (Y.O.) · Winship Cancer Institute of Emory University, Atlanta (S.S.R.) · Vanderbilt Ingram Cancer Center, Nashville (L.H.) · Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC (D.H.) · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona (E.F.) · and AstraZeneca, Macclesfield (P.F., M.C., K.H.B., P.A.D., S.G.), and University of Manchester, Christie Hospital, Manchester (M.R.) - both in the United Kingdom. · Pubmed 25923549
  • MD Anderson Cancer Center, The University of Texas, Houston, USA · Department of Pulmonary Diseases, Vrije Universiteit VU Medical Centre, Amsterdam, The Netherlands. · Medical Oncology Department, Gustave Roussy (GR), Villejuif, France. · Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. · Department of Respiratory Medicine, Hôpital Tenon, Assistance Publique - Hôpitaux de Paris, Paris, France. · European Institute of Oncology, Milan, Italy. · Duke University Medical Center, Durham, USA. · Korányi National Institute of Tuberculosis and Pulmonology, Budapest, Hungary. · Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. · IU Melvin and Bren Simon Cancer Center, Indianapolis, USA. · Yonsei Cancer Center, Division of Medical Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea. · Hopital Larrey CHU Toulouse, Toulouse, France. · Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · GlaxoSmithKline, Collegeville, USA. · GlaxoSmithKline Kft., Budapest, Hungary. · Lowe Center for Thoracic Oncology, Belfer Institute for Applied Cancer Science Dana-Farber Cancer Institute, Boston, USA. · Pubmed 25722381
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Electronic address: · Hôpital Larrey, Centre Hospitalier Universitaire de Toulouse, Toulouse, France. · L'Institut Gustave Roussy, Villejuif, France. · University of North Carolina School of Medicine, Chapel Hill, NC, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Centre Hospitalier Universitaire de Rennes, Rennes, France. · Ospedale S Maria, Terni, Italy. · Nouvel Hôpital Civil Chru de Strasbourg, Strasbourg, France. · The Ohio State University Medical Center, Columbus, OH, USA. · Oncology Consultants, PA, Houston, TX, USA. · University of California Davis Cancer Center, Sacramento, CA, USA. · Mount Sinai Beth Israel Comprehensive Cancer Center, New York, NY, USA. · Lehigh Valley Hospital, Allentown, PA, USA. · Centre Hospitalier Universitaire de Caen, Caen, France. · Universitaetsklinik Koeln, Koeln, Germany. · Hospices Civils de Lyon, Ch Lyon Sud, Pierre Benite, France. · Ospedale Campo Di Marte, Lucca, Italy. · Istituto Toscano Tumori, Livorno, Italy. · Chi De Creteil, Creteil, France. · University Hospitals of Cleveland, Cleveland, OH, USA. · Providence Portland Medical Center, Portland, OR, USA. · University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA. · Evangelische Lungenklinik Berlin, Berlin, Germany. · Klinikum der Universitaet Muenchen-Innenstadt, German Center for Lung Research, Munich, Germany. · Bristol-Myers Squibb, Princeton, NJ, USA. · Winship Cancer Institute, Emory University, Atlanta, GA, USA. · Pubmed 25704439
  • Department of Medical Oncology, Gustave Roussy, Villejuif · Department of Medical Oncology, Gustave Roussy, Villejuif. · Department of Medical Oncology, Gustave Roussy, Villejuif INSERM U981, Gustave Roussy, University Paris XI, Villejuif, France. · Drug Development Department (DITEP), Gustave Roussy, and University Paris-Sud, Villejuif. · Department of Medical Biology and Pathology. · Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif. · Drug Development Department (DITEP), Gustave Roussy, and University Paris-Sud, Villejuif INSERM U981, Gustave Roussy, University Paris XI, Villejuif, France. · Pubmed 26269204
  • INSERM U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", University of Paris-Sud XI, Gustave Roussy, Villejuif Translational Research Laboratory, Gustave Roussy, Villejuif. · Departments of Biopathology, Gustave Roussy, Villejuif, France. · INSERM U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", University of Paris-Sud XI, Gustave Roussy, Villejuif Translational Research Laboratory, Gustave Roussy, Villejuif Departments of Biopathology, Gustave Roussy, Villejuif, France. · Translational Research Laboratory, Gustave Roussy, Villejuif. · Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France. · Medicine, Gustave Roussy, Villejuif, France. · INSERM U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", University of Paris-Sud XI, Gustave Roussy, Villejuif Medicine, Gustave Roussy, Villejuif, France. · INSERM U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment", University of Paris-Sud XI, Gustave Roussy, Villejuif Translational Research Laboratory, Gustave Roussy, Villejuif · Pubmed 25846554
  • Thoracic Group, INSERM U981, Gustave Roussy, Villejuif, France Faculty of Medicine, University of Toronto, Ontario, Canada. · Thoracic Group, INSERM U981, Gustave Roussy, Villejuif, France Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculty of Medicine, University of Toronto, Ontario, Canada. · Translational Research Laboratory, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France Pulmonary Department, Percy Hospital, Paris, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Pubmed 25519011
  • Drug Development Dept, Gustave Roussy Cancer Campus, University Paris-Sud, Villejuif, France. · Medical Oncology Dept, Gustave Roussy Cancer Campus, Villejuif, France. · Drug Development Dept, Gustave Roussy Cancer Campus, University Paris-Sud, Villejuif, France · Pubmed 25882801
2014
  • Thoracic Group, INSERM U981, Gustave Roussy, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France. · Drug Development Department, Gustave Roussy, Villejuif, France. · Thoracic Group, INSERM U981, Gustave Roussy, Villejuif, France; Drug Development Department, Gustave Roussy, Villejuif, France. · Drug Development Department, Gustave Roussy, Villejuif, France; Pulmonary Department, Percy Hospital, Paris, France. · Pubmed 24882384
  • CHITS Toulon, Hôpital de Toulon, Service de pneumologie, 54, rue Sainte-Claire-Deville, 83056 Toulon, France. · Université Claude-Bernard Lyon 1, Hospices civils de Lyon, Hôpital Louis-Pradel, Service de pneumologie, 69677 Lyon, France. · Université Lille Nord de France, CHRU de Lille, Service de pneumologie et oncologie thoracique, 59000 Lille, France. · Nouvel Hôpital civil, Service de pneumologie, 67091 Strasbourg, France. · Hôpital de Mulhouse, Service de pneumologie, 68100 Mulhouse, France. · Gustave-Roussy, Service d'oncologie médicale, 94805 Villejuif, France. · CHU Côte-de-Nacre, Service de pneumologie et oncologie thoracique, 14033 Caen, France. · CHRU de Grenoble, Hôpital Michallon, Service de pneumologie, 38043 Grenoble, France. · AP-HP, Hôpital Tenon, Service de pneumologie et Sorbonne Universités, UPMC Univ 75006 Paris 06 - GRC n̊ 04, Theranoscan 75970 Paris, France. · AP-HP Marseille, Université Aix-Marseille, Service d'oncologie multidisciplinaire & innovations thérapeutiques, 13015 Marseille, France. · Pubmed 25299566
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department of Medical Oncology, University Hospital, Udine, Italy. Electronic address: · Department of Radiology, Gustave Roussy, Villejuif, France. · Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department of Second Medical Oncology, Oncologic Venetian Institute, Padua, Italy. · Translational Research Laboratory, Gustave Roussy, Villejuif, France. · Pubmed 24439569
2013
  • Department of Medical Oncology (Thoracic Unit), Institut-Gustave-Roussy, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France. · Pubmed 23371030
2012
  • French Institute of Health and Medical Research U981 Thoracic Unit, Gustave Roussy Institute, Villejuif, France. · Pubmed 22415779
2011
  • Medical Oncology Department, Institut Gustave Roussy, Villejuif, France. · Pubmed 21943984
  • Département de Médecine, Institut Gustave Roussy, Villejuif, France. · Pubmed 21916570
  • Département d'oncologie médicale, institut Gustave Roussy, 114, rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 21777766
2010
  • Unité Inserm U981, institut Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France. · Pubmed 20403548
2009
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 19995647
  • Institut Gustave-Roussy, Département de médecine, 39, rue Camille-Desmoulins, 94805 Villejuif, France. · Pubmed 20034871
  • Medical Oncology and Translational Research, Institut de Cancérologie Gustave Roussy,Villejuif, France. · Pubmed 19297315
2018
  • From the Department of Medicine, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center, Nashville, TN. · Pubmed 30231382
  • From the H. Lee Moffitt Cancer Center and Research Institute, Tampa (S.J.A., A.C., J.E.G.), Cancer Specialists of North Florida, Jacksonville (A.V.), Florida Cancer Specialists, Fleming Island (A.V.), and Florida Hospital Cancer Institute, Orlando (T.M.) - all in Florida · Tennessee Oncology, Chattanooga (D.D.), and Sarah Cannon Research Institute, Nashville (D.D., D.R.S.) - both in Tennessee · Hospital Universitario Virgen Macarena, Seville (D.V.), and Hospital Universitario 12 de Octubre, CiberOnc, Universidad Complutense and Spanish National Cancer Research Center (L.P.-A.), and Hospital Universitario La Paz (J.C.C.), Madrid - all in Spain · Kanagawa Cancer Center, Yokohama (S.M.), Kansai Medical University Hospital, Hirakata (T.K.), Kurume University Hospital, Kurume (T.T.), and Nippon Medical School Hospital, Tokyo (K.K.) - all in Japan · Westmead Hospital and the University of Sydney, Sydney (R.H.), and Flinders University and Flinders Medical Centre, Adelaide, SA (C.S.K.) - all in Australia · Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju (K.H.L.), Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju (Y.-C.K.) - all in South Korea · Vivantes Klinikum Neukoelln, Berlin (M.W.), and the Lung Clinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf (M.R.) - both in Germany · Centre Hospitalier Universitaire de Liège, Liège (M.B.), and University Hospitals KU Leuven, Leuven (J.V.) - both in Belgium · Centre Hospitalier Universitaire de Montpellier and Institut du Cancer de Montpellier Val d'Aurelle, Montpellier (X.Q.), Institut Gustave Roussy, Villejuif (D.P.), and Institut de Cancérologie de l'Ouest-site René Gauducheau, Saint Herblain (S.H.) - all in France · National Koranyi Institute of Pulmonology, Budapest, Hungary (G.O.) · the University of Manchester and the Christie NHS Foundation Trust, Manchester (C.F.-F.), AstraZeneca, Alderley Park (C.W.), and AstraZeneca, Cambridge (M.T.) - all in the United Kingdom · AstraZeneca, Gaithersburg, MD (G.M., P.A.D.) · and Istanbul University-Cerrahpasa, Cerrahpasa School of Medicine, Istanbul, Turkey (M.Ö.). · Pubmed 30280658
2017
  • From the Department of Oncology Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Department of Oncology Medicine, Hospital de la Vall d'Hebron, Barcelona, Spain; Institut National du Cancer, Boulogne-Billancourt, France; University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 28561640
  • From the H. Lee Moffitt Cancer Center and Research Institute, Tampa (S.J.A., A.C., J.E.G.), Cancer Specialists of North Florida, Jacksonville (A.V.), and Florida Hospital Cancer Institute, Orlando (T.M.) - all in Florida · Tennessee Oncology, Chattanooga, and Sarah Cannon Research Institute, Nashville - both in Tennessee (D.D.) · Hospital Universitario Virgen Macarena, Seville (D.V.), and Hospital Universitario 12 de Octubre, Centro de Investigación Biomédica en Red de Cáncer, Universidad Complutense and the Spanish National Cancer Research Center (L.P.-A.), and Hospital Universitario La Paz (J.C.C.), Madrid - all in Spain · Kanagawa Cancer Center, Yokohama (S.M.), Kansai Medical University Hospital, Hirakata (T.Y.), Kurume University Hospital, Kurume (T.T.), and Nippon Medical School Hospital, Tokyo (K.K.) - all in Japan · Westmead Hospital and the University of Sydney, Sydney (R.H.), and Flinders University and Flinders Medical Centre, Bedford Park, SA (C.S.K.) - all in Australia · Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju (K.H.L.), Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju (Y.-C.K.) - all in South Korea · Vivantes Klinikum Neukölln, Berlin (M.W.) · Centre Hospitalier Universitaire de Liège, Liège, Belgium (M.B.) · Centre Hospitalier Universitaire Montpellier and Cancer Institute of Montpellier Val d'Aurelle, Montpellier (X.Q.), Institut Gustave Roussy, Villejuif (D.P.), and Institut de Cancérologie de l'Ouest-Site René Gauducheau, Saint Herblain (S.H.) - all in France · National Koranyi Institute of Pulmonology, Budapest, Hungary (G.O.) · AstraZeneca, Alderley Park, United Kingdom (C.W.) · AstraZeneca, Gaithersburg, MD (G.M., H.J., Y.H., P.A.D.) · and Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey (M.Ö.). · Pubmed 28885881
2016
  • aMedical Oncology DepartmentbLaboratoire d'immunomonitoring en Oncologie UMS 3655 CNRS/US 23 INSERM, Gustave Roussy, Villejuif, France. · Pubmed 26756384
2015
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Pubmed 26001149
2013
  • Service des urgences, CLAN institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805 Villejuif cedex, France. · Pubmed 23835321
  • SITEP (Service des Innovations Therapeutiques Precoces), Department of Medicine, Institut Gustave Roussy, Paris XI University, Villejuif, France. · Pubmed 23774150
  • Institut de Cancérologie Gustave Roussy, Villejuif, France. · Pubmed 23669222
2012
  • Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France. · Pubmed 23582924
  • Département de Médecine, Institut Gustave Roussy, Villejuif, France. · Pubmed 22186627
  • Departments of Medicine and Biostatistics, Institut Gustave Roussy, Villejuif, France. · Pubmed 22617247
2011
  • Institut Gustave-Roussy, université Paris-Sud, Inserm U, Villejuif, France. · Pubmed 21459711
  • Institut Gustave-Roussy, département de médecine, 94805 Villejuif, France. · Pubmed 21420271
  • University of Paris-Sud, INSERM U981 'Identification of molecular predictors and new targets for cancer treatment', Institut de Cancérologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 21970878
2010
  • Département de médecine, Institut Gustave-Roussy, 94805 Villejuif. · Pubmed 20225562
  • Department of Medicine, Biostatistics and Epidemiology Unit, Translational Research Laboratory, Paris-Sud University, Gustave-Roussy Institute, Villejuif, France. · Pubmed 20145178
Universite Paris-Saclay
2018
  • Radiation oncology department, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM 1030, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Department of Radiology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · Université Paris Sud, Université Paris Saclay, Faculté de médecine du Kremlin-Bicetre, Le Kremlin-Bicetre, France. · Pubmed 30304046
2017
  • Département Interdisciplinaire de Soins de Support, Gustave-Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, F-94805, Villejuif, France. · Service de Biostatistique et d'Epidémiologie, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France. · Université Paris-Saclay, Univ. Paris-Sud, UVSQ, CESP, INSERM, F-94805, Villejuif, France. · Département d'Oncologie Médicale, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France. · Département Interdisciplinaire de Soins de Support, Gustave-Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, F-94805, Villejuif, France. · Département Ambulatoire, Gustave-Roussy, Université Paris-Saclay, F-94805, Villejuif, France. · Pubmed 28593463
  • Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and new Targets for Cancer Treatment," Villejuif, France. · Univ Paris Sud, Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicetre, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, Villejuif, France. · Univ Paris-Sud, Université Paris-Saclay, Faculty of Pharmacy, Châtenay-Malabry, France. · Gustave Roussy, Université Paris-Saclay, Department of Medicine, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France. · Pubmed 28461563
2017
  • From the Department of Oncology Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Department of Oncology Medicine, Hospital de la Vall d'Hebron, Barcelona, Spain; Institut National du Cancer, Boulogne-Billancourt, France; University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 28561640
Universite Paris 11 Sud
2018
  • From Gustave Roussy Cancer Campus and University Paris-Sud, Orsay, France (J.-C.S., D.P.) · the Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo (Y.O.), the Department of Thoracic Oncology, Osaka International Cancer Institute (F.I.), and the Department of Thoracic Oncology, Kansai Medical University Hospital (T.K.), Osaka, the Department of Thoracic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama (N.N.), and the Research Institute for Diseases of the Chest, Graduate School of Medical Science, Kyushu University, Fukuoka (I.O.) - all in Japan · the Respiratory Oncology Unit, University Hospital KU Leuven, Leuven, Belgium (J.V.) · Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok (T.R.), the Oncology Unit, Department of Medicine, Chiang Mai University, Chiang Mai (B.C.), and the Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai (A.D.) - all in Thailand · the Division of Medical Oncology, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheong-ju (K.H.L.), the Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and the Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon (E.K.C.) - all in South Korea · Pulmonary Hospital of Tongji University, Shanghai (C.Z.), and Jilin Provincial Cancer Hospital, Changchun (Y.C.) - both in China · Hospital Umum Sarawak, Kuching, Malaysia (P.J.V.) · National Cheng Kung University, Tainan, Taiwan (W.-C.S.) · the Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (J.E.G.) · the Department of Oncology, University College London Hospitals Biomedical Research Centre, and the Cancer Research UK Lung Cancer Centre of Excellence, London (S.-M.L.), and AstraZeneca, Cambridge (R.H., M.M., Y.R.) - all in the United Kingdom · and Emory University School of Medicine, Winship Cancer Institute, Atlanta (S.S.R.). · Pubmed 29151359
2017
  • From the Department of Oncology Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Department of Oncology Medicine, Hospital de la Vall d'Hebron, Barcelona, Spain; Institut National du Cancer, Boulogne-Billancourt, France; University Paris-Sud and Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 28561640
2013
  • SITEP (Service des Innovations Therapeutiques Precoces), Department of Medicine, Institut Gustave Roussy, Paris XI University, Villejuif, France. · Pubmed 23774150
2011
  • Institut Gustave-Roussy, université Paris-Sud, Inserm U, Villejuif, France. · Pubmed 21459711
  • University of Paris-Sud, INSERM U981 'Identification of molecular predictors and new targets for cancer treatment', Institut de Cancérologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 21970878
2010
  • Department of Medicine, Biostatistics and Epidemiology Unit, Translational Research Laboratory, Paris-Sud University, Gustave-Roussy Institute, Villejuif, France. · Pubmed 20145178
INSERM France
2015
  • Thoracic Group, INSERM U981, Gustave Roussy, Villejuif, France Faculty of Medicine, University of Toronto, Ontario, Canada. · Thoracic Group, INSERM U981, Gustave Roussy, Villejuif, France Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculty of Medicine, University of Toronto, Ontario, Canada. · Translational Research Laboratory, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France Pulmonary Department, Percy Hospital, Paris, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Pubmed 25519011
2014
  • Thoracic Group, INSERM U981, Gustave Roussy, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France. · Drug Development Department, Gustave Roussy, Villejuif, France. · Thoracic Group, INSERM U981, Gustave Roussy, Villejuif, France; Drug Development Department, Gustave Roussy, Villejuif, France. · Drug Development Department, Gustave Roussy, Villejuif, France; Pulmonary Department, Percy Hospital, Paris, France. · Pubmed 24882384
2010
  • Unité Inserm U981, institut Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France. · Pubmed 20403548
2016
  • aMedical Oncology DepartmentbLaboratoire d'immunomonitoring en Oncologie UMS 3655 CNRS/US 23 INSERM, Gustave Roussy, Villejuif, France. · Pubmed 26756384
2011
  • Institut Gustave-Roussy, université Paris-Sud, Inserm U, Villejuif, France. · Pubmed 21459711
  • University of Paris-Sud, INSERM U981 'Identification of molecular predictors and new targets for cancer treatment', Institut de Cancérologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 21970878
14 Other Locations Show
Yearly article counts 012161214344654
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.